Asymptomatic Carotid Lesions and Cognitive Impairment: Does Intervention Play a Role?

This study was designed to determine the effect of carotid endarterectomy/angioplasty on early (baseline vs. 3 months) and late (baseline vs. >5 months) cognitive function in patients with asymptomatic lesions.

This systematic research included 31 non-randomized studies.

Regarding the immediate post-operative period, 24 of these papers reported significant improvement in cognitive function; one study reported significant deterioration; three showed mixed results (some scores improved and others worsened), and the rest showed no changes.

In the late post-operative period (that is, well after endarterectomy or angioplasty), one study reported worse cognitive function, another showed significant improvement, some obtained mixed results, and most showed no change from baseline.

These results showed a similar distribution when comparing small studies with larger ones, controlled vs. uncontrolled studies, studies that used endarterectomy vs. others that used angioplasty, and studies with longer or shorter follow-up.


Read also: HOST-EXAM: The Study that Challenges Aspirin as Long-Term Antiplatelet Therapy.


Conclusion

Intervention, whether it be endarterectomy or angioplasty, rarely improves long-term cognitive function (<2%). However, it rarely makes it worse (in fact, magnitude is similar: 2%).

In the long term, the vast majority of papers (69%) could not prove an improvement in cognitive function. Only a few studies indicated improvement. The rest reported no change.

Until we have new papers that better identify the most vulnerable patients (with poor functional reserve) or provide clear evidence that silent embolism from a diseased carotid artery does indeed lead to cognitive impairment, we will remain in a sea of speculation.

Original title: Effect of Carotid Interventions on Cognitive Function in Patients With Asymptomatic Carotid Stenosis: A Systematic Review.

Reference: Stefano Ancetti et al. Eur J Vasc Endovasc Surg. 2021 Aug 30;S1078-5884(21)00604-3. Online ahead of print. doi: 10.1016/j.ejvs.2021.07.012. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Duration of Smoking Cessation and Risk of Amputation After Revascularization in Critical Limb Ischemia

Critical limb ischemia (CLI) is associated with high rates of amputation and mortality. Although smoking cessation improves outcomes after revascularization, the impact of the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...